HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications

Osteoarthritis is a common age-related joint degenerative disease. Pain, swelling, brief morning stiffness, and functional limitations are its main characteristics. There are still no well-established strategies to cure osteoarthritis. Therefore, better clarification of mechanisms associated with th...

Full description

Bibliographic Details
Main Authors: Chu-Yang Zeng, Xi-Feng Wang, Fu-Zhou Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.927126/full
_version_ 1811324203342757888
author Chu-Yang Zeng
Chu-Yang Zeng
Xi-Feng Wang
Fu-Zhou Hua
author_facet Chu-Yang Zeng
Chu-Yang Zeng
Xi-Feng Wang
Fu-Zhou Hua
author_sort Chu-Yang Zeng
collection DOAJ
description Osteoarthritis is a common age-related joint degenerative disease. Pain, swelling, brief morning stiffness, and functional limitations are its main characteristics. There are still no well-established strategies to cure osteoarthritis. Therefore, better clarification of mechanisms associated with the onset and progression of osteoarthritis is critical to provide a theoretical basis for the establishment of novel preventive and therapeutic strategies. Chondrocytes exist in a hypoxic environment, and HIF-1α plays a vital role in regulating hypoxic response. HIF-1α responds to cellular oxygenation decreases in tissue regulating survival and growth arrest of chondrocytes. The activation of HIF-1α could regulate autophagy and apoptosis of chondrocytes, decrease inflammatory cytokine synthesis, and regulate the chondrocyte extracellular matrix environment. Moreover, it could maintain the chondrogenic phenotype that regulates glycolysis and the mitochondrial function of osteoarthritis, resulting in a denser collagen matrix that delays cartilage degradation. Thus, HIF-1α is likely to be a crucial therapeutic target for osteoarthritis via regulating chondrocyte inflammation and metabolism. In this review, we summarize the mechanism of hypoxia in the pathogenic mechanisms of osteoarthritis, and focus on a series of therapeutic treatments targeting HIF-1α for osteoarthritis. Further clarification of the regulatory mechanisms of HIF-1α in osteoarthritis may provide more useful clues to developing novel osteoarthritis treatment strategies.
first_indexed 2024-04-13T14:10:07Z
format Article
id doaj.art-af792b6b5c224a5291276ddbaf5699e7
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T14:10:07Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-af792b6b5c224a5291276ddbaf5699e72022-12-22T02:43:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-07-011310.3389/fphar.2022.927126927126HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic ImplicationsChu-Yang Zeng0Chu-Yang Zeng1Xi-Feng Wang2Fu-Zhou Hua3Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Rehabilitation Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Anesthesiology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaOsteoarthritis is a common age-related joint degenerative disease. Pain, swelling, brief morning stiffness, and functional limitations are its main characteristics. There are still no well-established strategies to cure osteoarthritis. Therefore, better clarification of mechanisms associated with the onset and progression of osteoarthritis is critical to provide a theoretical basis for the establishment of novel preventive and therapeutic strategies. Chondrocytes exist in a hypoxic environment, and HIF-1α plays a vital role in regulating hypoxic response. HIF-1α responds to cellular oxygenation decreases in tissue regulating survival and growth arrest of chondrocytes. The activation of HIF-1α could regulate autophagy and apoptosis of chondrocytes, decrease inflammatory cytokine synthesis, and regulate the chondrocyte extracellular matrix environment. Moreover, it could maintain the chondrogenic phenotype that regulates glycolysis and the mitochondrial function of osteoarthritis, resulting in a denser collagen matrix that delays cartilage degradation. Thus, HIF-1α is likely to be a crucial therapeutic target for osteoarthritis via regulating chondrocyte inflammation and metabolism. In this review, we summarize the mechanism of hypoxia in the pathogenic mechanisms of osteoarthritis, and focus on a series of therapeutic treatments targeting HIF-1α for osteoarthritis. Further clarification of the regulatory mechanisms of HIF-1α in osteoarthritis may provide more useful clues to developing novel osteoarthritis treatment strategies.https://www.frontiersin.org/articles/10.3389/fphar.2022.927126/fullosteoarthritisHIF-1αhypoxiachondrocytesglycolysismitophagy
spellingShingle Chu-Yang Zeng
Chu-Yang Zeng
Xi-Feng Wang
Fu-Zhou Hua
HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
Frontiers in Pharmacology
osteoarthritis
HIF-1α
hypoxia
chondrocytes
glycolysis
mitophagy
title HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
title_full HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
title_fullStr HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
title_full_unstemmed HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
title_short HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
title_sort hif 1α in osteoarthritis from pathogenesis to therapeutic implications
topic osteoarthritis
HIF-1α
hypoxia
chondrocytes
glycolysis
mitophagy
url https://www.frontiersin.org/articles/10.3389/fphar.2022.927126/full
work_keys_str_mv AT chuyangzeng hif1ainosteoarthritisfrompathogenesistotherapeuticimplications
AT chuyangzeng hif1ainosteoarthritisfrompathogenesistotherapeuticimplications
AT xifengwang hif1ainosteoarthritisfrompathogenesistotherapeuticimplications
AT fuzhouhua hif1ainosteoarthritisfrompathogenesistotherapeuticimplications